Keyphrases
High-grade Glioma
100%
Re-irradiation
100%
Radiotherapy
66%
Late Toxicity
66%
Headache
33%
Disease Control
33%
Treatment Options
33%
White Matter Changes
33%
Late Effects
33%
MRI-guided
33%
Dose Volume
33%
Ethyl
33%
Tumor Volume
33%
Fluoro
33%
Median Overall Survival
33%
Glioblastoma
33%
Phase I Trial
33%
Median Progression-free Survival
33%
Large Tumors
33%
Gross Tumor Volume
33%
Irradiated Volume
33%
Tyrosine
33%
Contrast-enhanced MRI
33%
Volumetric Modulated Arc Therapy
33%
Progression-free
33%
Dose Prescription
33%
Glioma Grading
33%
T1 Contrast
33%
Radionecrosis
33%
Radiotherapy Dose Fractionation
33%
Medicine and Dentistry
Radiation Therapy
100%
Ganglioglioma
100%
Re-Irradiation
100%
Neoplasm
66%
Magnetic Resonance Imaging
66%
Positron Emission Tomography
66%
Progression Free Survival
66%
Disease
33%
Side Effect
33%
Adverse Event
33%
Headache
33%
Overall Survival
33%
Glioblastoma
33%
Phase I Trials
33%
Radiation Dose Fractionation
33%
Radiation Necrosis
33%
Volumetric Modulated Arc Therapy
33%
T1 Contrast
33%
Pharmacology, Toxicology and Pharmaceutical Science
Glioma
100%
Neoplasm
66%
Progression Free Survival
66%
Side Effect
33%
Disease
33%
Headache
33%
Adverse Event
33%
Overall Survival
33%
Glioblastoma
33%
Phase I Trials
33%
Radiation Necrosis
33%
Dose Fractionation
33%